Select Medical Receives Executive Chairman's Buyout Proposal: Board Begins Evaluation Process
Market Chameleon (Tue, 25-Nov 4:21 AM ET)
Select Medical Holdings Corporation Acknowledges Executive Chairman's Take-Private Proposal
PRNewswire (Mon, 24-Nov 8:30 PM ET)
PRNewswire (Thu, 30-Oct 4:30 PM ET)
PRNewswire (Thu, 2-Oct 4:15 PM ET)
Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.
Select Medical Hldgs trades on the NYSE stock market under the symbol SEM.
As of December 18, 2025, SEM stock price declined to $14.90 with 228,523 million shares trading.
SEM has a beta of 0.73, meaning it tends to be less sensitive to market movements. SEM has a correlation of 0.12 to the broad based SPY ETF.
SEM has a market cap of $1.84 billion. This is considered a Small Cap stock.
Last quarter Select Medical Hldgs reported $1 billion in Revenue and $.23 earnings per share. This beat revenue expectation by $37 million and exceeded earnings estimates by $.07.
In the last 3 years, SEM traded as high as $22.07 and as low as $11.46.
The top ETF exchange traded funds that SEM belongs to (by Net Assets): IJR, VTI, IWM, VB, VBR.
SEM has underperformed the market in the last year with a price return of -20.8% while the SPY ETF gained +13.7%. However, in the short term, SEM had mixed performance relative to the market. It has outperformed in the last 3 months, returning +21.9% vs +3.4% return in SPY. But in the last 2 weeks, SEM shares have been beat by the market, returning -1.1% compared to an SPY return of -0.6%.
SEM support price is $14.69 and resistance is $15.33 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SEM shares will trade within this expected range on the day.